12:00 AM
 | 
Jan 28, 2016
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Interleukin-33 (IL-33; NF-HEV); interleukin-1 receptor-like 1 (IL1RL1; ST2)

Ophthalmic disease

INDICATION: Age-related macular degeneration (AMD)

Patient sample and mouse studies suggest IL-33 inhibitors could help treat AMD. Retinal levels of IL-33 were higher in postmortem eyes from patients with advanced AMD than in eyes from unaffected, age-matched controls....

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >